Responding to major global trends
As the standard of medical care improves, human life expectancy has risen considerably, leading to greater demand for new and specific drugs. Demand for food, too, is growing in step with global population growth and higher standards of living.
The production of drugs is a complex, multi-stage processes that involve not only the pharmaceuticals industry, but also a variety of other industrial sectors. The fine chemicals industry produces intermediate products and active substances for the pharmaceuticals industry and also supplies food manufacturers with intermediates and additives.
CABB supplies the pharmaceuticals and fine chemicals industries with reagents, intermediates and customer-specific multi-stage building blocks in line with its strategy of offering its customers sustainable, innovative solutions.
CABB operates production facilities and technologies that are ideally suited to the requirements of the pharmaceutical and fine chemicals industries. We accomplish demanding multi-stage syntheses and are able to meet volume needs all the way from pilot project-scale volumes to major commercial operations, making CABB a valuable player in the growing global health and nutrition sector.